Therefore, we believe that at least in nonmelanoma skin cancer, CRH does not promote tumor growth per se, but rather exerts its effects on the tumor stroma by increasing tumor vasculature and reducing an effective immune response. This evidence concerns the gene CRH and neoplasm.